Public Citizen asks the FDA to Prohibit Traditional Compounding Pharmacies from Engaging in High Risk Sterile Compounding
Public Citizen has requested that the Food and Drug Administration (FDA) prohibit traditional compounding pharmacies from engaging in nonsterile-to-sterile compounding, a particularly high-risk form of compounding, by identifying these drugs as demonstrably difficult to compound. Public Citizen also recommended that the FDA restrict compounding of metered dose inhalers, dry powder inhalers, transdermal delivery systems, sustained or time-released dosage forms, and enteric-coated preparations.